A series of WHO PQ triggers vaccines development of domestic pharmaceutical companies

A series of the WHO PQs by domestic pharmaceutical and biopharmaceutical companies are expected to accelerate the domestic vaccine development.

A pentavalent complex vaccine developed by LG Life Sciences for the first time using domestic technology, ‘Eupenta’ has acquired prequalification from the WHO on the 11^th. It has been two months since ‘Euvichol,’ a Eubiologics’ oral cholera vaccine, re...